On November 19, 2009, the FDA issued a Safety Communication about problems with Powerheart and CardioVive automatic external defibrillators (AEDs). These devices are used for emergency treatment of victims with symptoms of sudden cardiac arrest who are unresponsive and not breathing. The document advises AED owners of certain precautions to follow.